Close Menu

NEW YORK (GenomeWeb) – T2 Biosystems today preliminarily reported a 50 percent increase year over year in product revenue growth for the fourth quarter of 2016.

The Lexington, Massachusetts-based diagnostics firm attributed the growth to an increase in T2Candida Panel sales associated with increased patient testing across the installed base. The firm also secured eight new contracts covering 18 hospitals in the US and Europe and has increased its worldwide installed base to include 143 hospitals with access to T2Dx Instruments.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.

Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.

Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.

In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.